Published in Int J Mol Sci on January 22, 2015
Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology (2016) 1.89
Molecular pathological epidemiology gives clues to paradoxical findings. Eur J Epidemiol (2015) 1.16
Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn (2015) 0.94
Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control (2015) 0.94
Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status. J Natl Cancer Inst (2015) 0.89
Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Oncotarget (2016) 0.83
Epigenetic alterations in gastric cancer (Review). Mol Med Rep (2015) 0.82
Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival. Oncotarget (2016) 0.81
Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review. Gastroenterol Res Pract (2015) 0.81
FAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatin. Sci Rep (2016) 0.80
Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis. Oncotarget (2017) 0.79
PRSS8 methylation and its significance in esophageal squamous cell carcinoma. Oncotarget (2016) 0.77
Role of Epigenetics in Biology and Human Diseases. Iran Biomed J (2016) 0.75
Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers. Cancer Inform (2016) 0.75
Discovery of genes from feces correlated with colorectal cancer progression. Oncol Lett (2016) 0.75
Measurement of DNA Length Changes Upon CpG Hypermethylation by Microfluidic Molecular Stretching. Cell Med (2016) 0.75
The Correlation Relationship between P14ARF Gene DNA Methylation and Primary Liver Cancer. Med Sci Monit (2015) 0.75
Aberrant Promoter Methylation at CpG Cytosines Induce the Upregulation of the E2F5 Gene in Breast Cancer. J Breast Cancer (2016) 0.75
Hypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancer. J Ovarian Res (2016) 0.75
Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells. Genet Res Int (2016) 0.75
Epigenetics and Colorectal Neoplasia: the Evidence for Physical Activity and Sedentary Behavior. Curr Colorectal Cancer Rep (2015) 0.75
Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition. Oncotarget (2017) 0.75
O-GlcNAc expression levels epigenetically regulate colon cancer tumorigenesis by affecting the cancer stem cell compartment via modulating expression of transcriptional factor MYBL1. J Biol Chem (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
The functions of animal microRNAs. Nature (2004) 64.85
The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
DNA methylation patterns and epigenetic memory. Genes Dev (2002) 33.83
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A (1992) 29.51
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63
CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med (2000) 12.34
microRNAs as oncogenes and tumor suppressors. Dev Biol (2006) 10.68
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A (2007) 9.82
The epigenetic progenitor origin of human cancer. Nat Rev Genet (2006) 9.65
The power and the promise of DNA methylation markers. Nat Rev Cancer (2003) 9.32
MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res (2000) 9.30
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78
Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer (2011) 7.69
Epigenetics in cancer. Carcinogenesis (2009) 7.49
Molecular genetics of colorectal cancer. Annu Rev Pathol (2011) 7.24
CpG island methylator phenotype in cancer. Nat Rev Cancer (2004) 7.13
Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov (2006) 6.39
Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev (2007) 5.63
Evaluation of the Infinium Methylation 450K technology. Epigenomics (2011) 4.90
Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res (2011) 4.84
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A (2007) 4.16
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut (2010) 4.01
CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn (2006) 3.98
The genetics and genomics of cancer. Nat Genet (2003) 3.97
Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst (1972) 3.78
Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst (2005) 3.73
Apoptosis and melanoma chemoresistance. Oncogene (2003) 3.58
A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst (2008) 3.54
CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res (1990) 3.46
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet (2007) 3.39
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res (2004) 3.23
Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res (2002) 3.21
Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol (2011) 3.15
Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell (2002) 3.09
LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One (2007) 2.99
Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst (2001) 2.93
Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One (2008) 2.92
LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer (2008) 2.87
Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res (2008) 2.83
Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science (2005) 2.72
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res (2002) 2.71
DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem (2007) 2.65
Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One (2008) 2.46
The septin family of GTPases: architecture and dynamics. Nat Rev Mol Cell Biol (2008) 2.38
Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol (2009) 2.34
Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology (2000) 2.25
N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst (2009) 2.22
CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol (2009) 2.17
Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res (2006) 2.13
Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res (2009) 2.03
Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol (2006) 1.99
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol (2013) 1.95
TFAP2E-DKK4 and chemoresistance in colorectal cancer. N Engl J Med (2012) 1.94
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med (2011) 1.93
Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol (2003) 1.90
MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer (2009) 1.88
Cancer epigenetics: linking basic biology to clinical medicine. Cell Res (2011) 1.88
CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci U S A (2000) 1.86
Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet (2004) 1.80
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res (2009) 1.80
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res (2009) 1.78
Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. Virchows Arch (2009) 1.67
Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev (2007) 1.67
A real-time PCR assay for DNA-methylation using methylation-specific blockers. Nucleic Acids Res (2004) 1.63
Stool screening for colorectal cancer: molecular approaches. Gastroenterology (2005) 1.61
Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res (2005) 1.59
Epigenetic biomarkers for human cancer: the time is now. Crit Rev Oncol Hematol (2008) 1.57
Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection. Nucleic Acids Res (2008) 1.57
DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer (2010) 1.55
Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut (2009) 1.54
Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res (2002) 1.53
DNA methylation differences associated with tumor tissues identified by genome scanning analysis. Genomics (1998) 1.51
Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res (2001) 1.49
Colorectal cancer epigenetics: complex simplicity. J Clin Oncol (2011) 1.47
p16 gene methylation in colorectal cancer patients with long-term follow-up. Rev Esp Enferm Dig (2012) 1.45
A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol (2008) 1.40
The DNA methylome. FEBS Lett (2010) 1.38
Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut (2013) 1.37
Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clin Colorectal Cancer (2003) 1.35
Epigenetics and colorectal cancer pathogenesis. Cancers (Basel) (2013) 1.33
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis. Tumour Biol (2014) 1.29
Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am J Gastroenterol (2005) 1.26
A comparison of feature selection and classification methods in DNA methylation studies using the Illumina Infinium platform. BMC Bioinformatics (2012) 1.26
Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Gastroenterology (2006) 1.26
Microsatellite instability and survival in rectal cancer. Cancer Causes Control (2009) 1.24